692 Circulating tumor DNA analysis of advanced hepatocellular cancer (HCC) patients treated with neoantigen targeted personalized cancer DNA vaccine (GNOS-PV02) in combination with plasmid IL-12 (pIL12) and anti-PD1 (pembrolizumab)

Renzo Perales, Alfredo Perales-Puchalt, Gabor Bartha, Josette Northcott, Richard Chen, John Lyle, Dan Norton, Neil Cooch, Edward Gane, Mark Yarchoan, Thomas Marron, Sarah Rochestie (+4 others)
2022 Regular and Young Investigator Award Abstracts   unpublished
doi:10.1136/jitc-2022-sitc2022.0692 fatcat:daxs3cf3vvgpjpsmpyoliqn3qa